Brian M. Hahn
2018
In 2018, Brian M. Hahn earned a total compensation of $1.4M as Chief Financial Officer and Senior Vice President at GlycoMimetics, a 75% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $144,000 |
|---|---|
| Option Awards | $872,950 |
| Salary | $375,000 |
| Other | $5,447 |
| Total | $1,397,397 |
Hahn received $873K in option awards, accounting for 62% of the total pay in 2018.
Hahn also received $144K in non-equity incentive plan, $375K in salary and $5.4K in other compensation.
Rankings
In 2018, Brian M. Hahn's compensation ranked 7,516th out of 14,244 executives tracked by ExecPay. In other words, Hahn earned more than 47.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,516 out of 14,244 | 47th |
Division Manufacturing | 2,916 out of 5,765 | 49th |
Major group Chemicals And Allied Products | 1,095 out of 2,128 | 49th |
Industry group Drugs | 925 out of 1,817 | 49th |
Industry Pharmaceutical Preparations | 727 out of 1,391 | 48th |
Source: SEC filing on April 10, 2019.
Hahn's colleagues
We found three more compensation records of executives who worked with Brian M. Hahn at GlycoMimetics in 2018.
News
GlycoMimetics CEO Harout Semerjian's 2023 pay jumps 67% to $2.4M
April 1, 2024
GlycoMimetics CEO Harout Semerjian's 2022 pay falls 50% to $1.4M
April 21, 2023
GlycoMimetics CEO Harout Semerjian receives $2.9M in 2021
April 11, 2022
GlycoMimetics CEO Rachel King's 2018 pay jumps 105% to $3.2M
April 10, 2019